The impact of individual and combined cardiometabolic risk factors on cardiovascular disease (CVD) incidence.
Celltrion to build a $94M+ facility in South Korea — report
Korean biosimilar maker Celltrion will be constructing a new manufacturing facility in South Korea. A report from Korea Biomedical Review on Tuesday said that Celltrion